Iridex (IRIX) Gains from Investment Securities (2013 - 2019)
Iridex's (IRIX) quarterly Gains from Investment Securities came in at -$80000.0 in Q3 2019, down 305.13% year-on-year from $39000.0 in Q3 2018, and down 250.94% quarter-over-quarter from $53000.0 in Q2 2019.
Iridex (IRIX) Gains from Investment Securities (2013 - 2019) Analysis & Trends
Iridex's Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$80000.0 for Q3 2019.
- On a quarterly basis, Gains from Investment Securities fell 305.13% year-over-year to -$80000.0 in Q3 2019; TTM through Dec 2019 was $47000.0, a 68.46% decrease from a year earlier, with the FY2019 full-year figure at $47000.0, down 68.46% from the prior year.
- Gains from Investment Securities retreated to -$80000.0 in Q3 2019 per IRIX's latest filing, from $53000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $138000.0 in Q4 2017 and bottomed at -$298000.0 in Q1 2016.
- The 5-year median for Gains from Investment Securities is $29000.0 (2018), against an average of $15352.9.
- Across the five-year window, Gains from Investment Securities jumped 1433.33% in 2017 and sank 305.13% in 2019, its largest moves.
- Year by year, Gains from Investment Securities stood at $8000.0 in 2015, then rose by 12.5% to $9000.0 in 2016, then soared by 1433.33% to $138000.0 in 2017, then tumbled by 60.14% to $55000.0 in 2018, then tumbled by 245.45% to -$80000.0 in 2019.
- Per Business Quant, the three latest IRIX Gains from Investment Securities figures stand at -$80000.0 (Q3 2019), $53000.0 (Q2 2019), and $74000.0 (Q1 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 28, 2019 | -80,000.00 |
| Sep 28, 2019 | -80,000.00 |
| Jun 29, 2019 | 53,000.00 |
| Jun 29, 2019 | 53,000.00 |
| Mar 30, 2019 | 74,000.00 |
| Mar 30, 2019 | 74,000.00 |
| Dec 29, 2018 | 55,000.00 |
| Dec 29, 2018 | 55,000.00 |
| Sep 29, 2018 | 39,000.00 |
| Sep 29, 2018 | 39,000.00 |
| Jun 30, 2018 | 26,000.00 |
| Jun 30, 2018 | 26,000.00 |
| Mar 31, 2018 | 29,000.00 |
| Mar 31, 2018 | 29,000.00 |
| Dec 30, 2017 | 138,000.00 |
| Dec 30, 2017 | 138,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Jul 1, 2017 | 36,000.00 |
| Jul 1, 2017 | 36,000.00 |